Trimethylamine N-oxide (TMAO) is produced from the metabolism of dietary choline and L-carnitine by intestinal microbiota, and many studies have shown that this important product inhibits cholesterol metabolism, induces platelet aggregation and thrombosis, and promotes atherosclerosis
More clinical trials will help to unravel the potential of dietary interventions as an option for ME/CFS treatment
Diagnosis: PCOS: increased pregnancy rates (15 RCTs, 1,908 women) Unexplained fertility: no difference in pregnancy rates (4 RCTs, 997 women) Tubal: no difference in pregnancy rates (2 RCTs, 71 women) Poor responders: no difference in pregnancy rates (1 RCT, 65 women) Poor ovarian reserve: no difference in pregnancy rates (2 RCTs, 266 women) Endometriosis: no difference in pregnancy rates (1 RCT, 280 women) Adverse events: Miscarriage: no difference (24 RCTs, 3,229 women) Multiple pregnancy: no difference (9 RCTs, 1,886 women) Ectopic pregnancy: no difference (7 RCTs, 308 women) Preterm birth: no difference (2 RCTs, 220 women) Placenta previa: no differences (1 RCT, 180 women) Preeclampsia: no difference (1 RCT, 160 women) N-acetyl-cysteine (NAC) NAC is a medication that can be used to treat Tylenol (acetaminophen) overdoses by increasing levels of the antioxidant glutathione
What does Mylans victory mean for the future of generic drugs and patient access
Suspected adverse reactions to any medicine can also be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
Eden and Ro are two companies that help individuals connect with licensed healthcare providers who may prescribe these medications when medically appropriate
